{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Abstract\n",
    "The objective of this notebook will be to perform keyword analysis on the papers for Covid-19 risk factors."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import glob\n",
    "import json\n",
    "from os import path\n",
    "import pandas as np\n",
    "import pandas as pd\n",
    "from datetime import datetime"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "papers_df = pd.read_csv('../output/papers_df.csv', \n",
    "                        index_col=0, \n",
    "                        keep_default_na=False,\n",
    "                       parse_dates=['publish_time'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "transmission_keywords = ['transmi', 'sneez', 'contact trac', 'reproduc', 'environ']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "smoke_keywords = ['smok']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "covid_keywords = ['COVID-19', 'HCoV-19', 'CORD-19' ,'2019-nCoV', 'Wuhan coronavirus', 'SARS-CoV-2', 'SARS-COV-2']\n",
    "covid_keywords = [word.lower() for word in covid_keywords]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "# covid_papers = papers_df[papers_df['text_body'].apply(lambda x : \n",
    "#                                                 any(key in x.lower() for\n",
    "#                                                     key in covid_keywords)\n",
    "#                                                )]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "json_files = glob.glob(f'../data/**/*.json', recursive=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "paper_dicts = []\n",
    "for file in json_files:\n",
    "    name = path.basename(file)\n",
    "    with open(file) as f:\n",
    "        data = json.load(f)\n",
    "    paper_obj = {'id':name,\n",
    "                 'data':data}\n",
    "    paper_dicts.append(paper_obj)    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [],
   "source": [
    "def tokenize(text):\n",
    "    text = text.lower().strip()\n",
    "    if text[-1] == 's':\n",
    "        text = text[:-1]\n",
    "    return text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "ename": "IndexError",
     "evalue": "string index out of range",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mIndexError\u001b[0m                                Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-59-8110e36f2e14>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      7\u001b[0m             \u001b[0mpaper_sections\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0madd\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mparagraph\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'section'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      8\u001b[0m     \u001b[1;32mfor\u001b[0m \u001b[0msection\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mpaper_sections\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 9\u001b[1;33m         \u001b[0msection\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mtokenize\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0msection\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     10\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[0msection\u001b[0m \u001b[1;32min\u001b[0m \u001b[0msections\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     11\u001b[0m             \u001b[0msections\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0msection\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m+=\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m<ipython-input-58-1e7dd242f05c>\u001b[0m in \u001b[0;36mtokenize\u001b[1;34m(text)\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[1;32mdef\u001b[0m \u001b[0mtokenize\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mtext\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      2\u001b[0m     \u001b[0mtext\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mtext\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mlower\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstrip\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 3\u001b[1;33m     \u001b[1;32mif\u001b[0m \u001b[0mtext\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;33m-\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m==\u001b[0m \u001b[1;34m's'\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m      4\u001b[0m         \u001b[0mtext\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mtext\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m-\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      5\u001b[0m     \u001b[1;32mreturn\u001b[0m \u001b[0mtext\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mIndexError\u001b[0m: string index out of range"
     ]
    }
   ],
   "source": [
    "sections = {}\n",
    "for paper in paper_dicts:\n",
    "    body = paper['data']['body_text']\n",
    "    paper_sections = set()\n",
    "    for paragraph in body:\n",
    "        if 'section' in paragraph:\n",
    "            paper_sections.add(paragraph['section'])\n",
    "    for section in paper_sections:\n",
    "        if len\n",
    "        section = tokenize(section)\n",
    "        if section in sections:\n",
    "            sections[section] += 1\n",
    "        else:\n",
    "            sections[section] = 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Introduction', 22693),\n",
       " ('Discussion', 19468),\n",
       " ('', 11778),\n",
       " ('Conclusions', 7052),\n",
       " ('Conclusion', 5688),\n",
       " ('Results', 5605),\n",
       " ('INTRODUCTION', 4455),\n",
       " ('DISCUSSION', 4052),\n",
       " ('Background', 3997),\n",
       " ('Statistical analysis', 3376),\n",
       " ('Methods', 1971),\n",
       " ('1. Introduction', 1383),\n",
       " ('RESULTS', 1360),\n",
       " ('Competing interests', 1182),\n",
       " ('Materials and methods', 1000),\n",
       " ('Statistical Analysis', 970),\n",
       " ('CONCLUSION', 778),\n",
       " ('Materials and Methods', 742),\n",
       " (\"Authors' contributions\", 739),\n",
       " ('CONCLUSIONS', 715),\n",
       " ('MATERIALS AND METHODS', 711),\n",
       " ('Results and discussion', 706),\n",
       " ('Statistical analysis ::: Methods', 674),\n",
       " ('Summary', 600),\n",
       " ('Funding', 582),\n",
       " ('Ethics statement', 549),\n",
       " ('4. Discussion', 528),\n",
       " ('Data analysis', 504),\n",
       " ('Statistical analysis ::: Materials and methods', 489),\n",
       " ('Statistics', 484),\n",
       " ('SUMMARY', 479),\n",
       " ('Animals', 474),\n",
       " ('Author Contributions', 471),\n",
       " ('Concluding remarks', 469),\n",
       " ('Statistical analyses', 439),\n",
       " ('Abbreviations', 430),\n",
       " ('Ethics Statement', 393),\n",
       " ('The Study', 393),\n",
       " ('Conflicts of interest', 390),\n",
       " ('Viruses', 389),\n",
       " ('Results and Discussion', 382),\n",
       " ('Study design', 377),\n",
       " ('AUTHOR CONTRIBUTIONS', 374),\n",
       " ('Western blot analysis', 369),\n",
       " ('Conflict of interest', 368),\n",
       " ('ACKNOWLEDGMENTS', 362),\n",
       " ('Statistical analysis ::: Materials and Methods', 359),\n",
       " ('Data collection', 354),\n",
       " ('Authorsâ€™ contributions', 354),\n",
       " ('Limitations', 352),\n",
       " ('Cells and viruses', 349),\n",
       " ('Conflict of Interest Statement', 344),\n",
       " ('METHODS', 343),\n",
       " ('Supporting Information', 336),\n",
       " ('Diagnosis', 334),\n",
       " ('Treatment', 327),\n",
       " ('5. Conclusions', 321),\n",
       " ('Supplementary Material', 309),\n",
       " ('Flow cytometry', 289),\n",
       " ('Materials', 279),\n",
       " ('Pre-publication history', 276),\n",
       " ('Study population', 275),\n",
       " ('Mice', 272),\n",
       " ('Author Summary', 272),\n",
       " ('Statistical Analysis ::: Materials and Methods', 271),\n",
       " ('Virus', 264),\n",
       " ('Concluding Remarks', 260),\n",
       " ('Epidemiology', 256),\n",
       " ('Western blotting', 251),\n",
       " ('Phylogenetic analysis', 246),\n",
       " ('ELISA', 244),\n",
       " ('Ethical approval', 241),\n",
       " ('Acknowledgments', 228),\n",
       " ('Sample collection', 227),\n",
       " ('Patients', 226),\n",
       " ('Cell culture', 223),\n",
       " ('Additional Information', 218),\n",
       " ('Antibodies', 217),\n",
       " ('2.', 207),\n",
       " ('Data', 206),\n",
       " ('Ethics statement ::: Materials and Methods', 206),\n",
       " ('a b s t r a c t', 200),\n",
       " ('Plasmids', 198),\n",
       " ('FUNDING', 195),\n",
       " ('Declaration of Competing Interest', 192),\n",
       " ('Cells', 189),\n",
       " ('Main', 186),\n",
       " ('Author contributions', 185),\n",
       " ('Statistical Analyses', 185),\n",
       " ('Immunohistochemistry', 183),\n",
       " ('Conflict of interest statement', 182),\n",
       " ('Objectives', 181),\n",
       " ('(which was not peer-reviewed)', 178),\n",
       " ('Experimental design', 178),\n",
       " ('4. Conclusions', 178),\n",
       " ('Participants', 176),\n",
       " ('Ethics Statement ::: Materials and Methods', 168),\n",
       " ('Contributors', 157),\n",
       " ('Statistical methods', 157),\n",
       " ('Histopathology', 157),\n",
       " ('Immunofluorescence', 157),\n",
       " ('Western blot', 156),\n",
       " ('Data Analysis', 155),\n",
       " ('Prevention', 154),\n",
       " ('Sequence analysis', 153),\n",
       " ('Influenza', 152),\n",
       " ('Electron microscopy', 152),\n",
       " ('Reagents', 151),\n",
       " ('Serology', 150),\n",
       " ('Definitions', 149),\n",
       " ('Ethics statement ::: Methods', 149),\n",
       " ('RNA extraction', 148),\n",
       " ('ARTICLE IN PRESS', 146),\n",
       " ('Data analysis ::: Methods', 144),\n",
       " ('Ethics', 141),\n",
       " ('Conflicts of Interest:', 139),\n",
       " ('Pathogenesis', 137),\n",
       " ('Virus isolation', 135),\n",
       " ('Cells and virus', 135),\n",
       " ('I. INTRODUCTION', 134),\n",
       " ('Declaration of interests', 134),\n",
       " ('SUPPLEMENTAL MATERIAL', 134),\n",
       " ('Plasmid construction', 132),\n",
       " ('Subjects', 129),\n",
       " ('Analysis', 129),\n",
       " ('Ethics statement ::: Materials and methods', 128),\n",
       " ('Role of the funding source', 126),\n",
       " ('Case report', 123),\n",
       " ('Contents lists available at ScienceDirect', 122),\n",
       " ('Statistical analysis ::: MATERIALS AND METHODS', 122),\n",
       " ('A B', 121),\n",
       " ('Study Design', 120),\n",
       " ('Samples', 119),\n",
       " ('4.', 119),\n",
       " ('Review', 119),\n",
       " ('Data availability', 118),\n",
       " ('5.', 118),\n",
       " ('Additional file', 118),\n",
       " ('Chemistry', 118),\n",
       " ('RESULTS AND DISCUSSION', 117),\n",
       " ('Viruses and cells', 116),\n",
       " ('DIAGNOSIS', 116),\n",
       " ('Data Availability', 115),\n",
       " ('Outcomes', 115),\n",
       " ('Histology', 114),\n",
       " ('Table 2', 114),\n",
       " ('3.', 111),\n",
       " ('Statistical Analysis ::: Methods', 111),\n",
       " ('Perspectives', 110),\n",
       " ('RT-PCR', 110),\n",
       " ('Ethical considerations', 108),\n",
       " ('Additional files', 108),\n",
       " ('Conflicts of Interest', 107),\n",
       " ('CONCLUDING REMARKS', 107),\n",
       " ('Virus and cells', 106),\n",
       " ('Bacteria', 106),\n",
       " ('Discussion and conclusions', 104),\n",
       " ('Material and methods', 103),\n",
       " ('Data sources', 103),\n",
       " ('Data collection ::: Methods', 103),\n",
       " ('IntroducciÃ³n', 103),\n",
       " ('1.', 102),\n",
       " ('Conflict of Interest Statement ::: Author Contributions', 102),\n",
       " ('Flow Cytometry', 101),\n",
       " ('Acknowledgements', 101),\n",
       " ('EPIDEMIOLOGY', 101),\n",
       " ('Method', 100),\n",
       " ('Sampling', 100),\n",
       " ('Protein expression and purification', 100),\n",
       " ('TREATMENT', 100),\n",
       " ('Study design ::: Methods', 100),\n",
       " ('Statistical analyses ::: Methods', 100),\n",
       " ('Vaccines', 99),\n",
       " ('Methodology', 99),\n",
       " ('Vaccination', 99),\n",
       " ('3. Discussion', 99),\n",
       " ('Findings', 97),\n",
       " ('Declaration of competing interest', 96),\n",
       " ('Data Collection', 95),\n",
       " ('Cell viability assay', 95),\n",
       " ('Clinical signs', 94),\n",
       " ('Tuberculosis', 93),\n",
       " ('Adenovirus', 93),\n",
       " ('Immunoblotting', 92),\n",
       " ('ETHICS STATEMENT', 92),\n",
       " ('Western Blot Analysis', 92),\n",
       " ('Etiology', 92),\n",
       " ('Prognosis', 92),\n",
       " ('SUPPLEMENTARY DATA', 91),\n",
       " ('Discussion and conclusion', 90),\n",
       " ('â€¢', 90),\n",
       " ('Disclaimer', 89),\n",
       " ('Study Population', 89),\n",
       " ('CONFLICT OF INTEREST', 88),\n",
       " ('Limitations ::: Discussion', 88),\n",
       " ('Conflict of interest statement ::: Author contributions', 88),\n",
       " ('Setting', 86),\n",
       " ('Rotavirus', 86),\n",
       " ('Enzyme-linked immunosorbent assay (ELISA)', 86),\n",
       " ('Future directions', 86),\n",
       " ('Management', 86),\n",
       " ('Cell lines', 85),\n",
       " ('Sensitivity analysis', 85),\n",
       " ('Virus titration', 85),\n",
       " ('Figure 2.', 84),\n",
       " ('Patient characteristics', 84),\n",
       " ('Statistics ::: Methods', 84),\n",
       " ('Real-time PCR', 83),\n",
       " ('Figure 2', 83),\n",
       " ('Procedures', 83),\n",
       " ('Literature review', 83),\n",
       " ('3. Results', 83),\n",
       " ('Conflict of Interest', 82),\n",
       " ('Cell Culture', 82),\n",
       " ('Chemicals', 82),\n",
       " ('Cytotoxicity assay', 82),\n",
       " ('Search strategy and selection criteria', 81),\n",
       " ('Discussions', 79),\n",
       " ('Malaria', 79),\n",
       " ('Transmission', 79),\n",
       " ('EXPERIMENTAL PROCEDURES', 78),\n",
       " ('Coronaviruses', 78),\n",
       " ('Table 1', 78),\n",
       " ('SUPPLEMENTARY MATERIAL', 77),\n",
       " ('Highlights', 77),\n",
       " ('I. Introduction', 76),\n",
       " ('Compliance with ethical standards', 76),\n",
       " ('Electron Microscopy', 76),\n",
       " ('Animals ::: Materials and Methods', 76),\n",
       " ('Nucleic acid extraction', 75),\n",
       " ('Conclusions and perspectives', 75),\n",
       " ('Cells and Viruses', 75),\n",
       " ('Confocal microscopy', 75),\n",
       " ('Fig. 2.', 75),\n",
       " ('Plaque assay', 74),\n",
       " ('Sequencing', 73),\n",
       " ('Clinical samples', 72),\n",
       " ('Coronavirus', 72),\n",
       " ('Expert commentary', 72),\n",
       " ('Five-year view', 72),\n",
       " ('Animals ::: Methods', 72),\n",
       " ('Added value of this study', 71),\n",
       " ('Phylogenetic Analysis', 71),\n",
       " ('Search strategy', 71),\n",
       " ('Clinical features', 71),\n",
       " ('Pathology', 71),\n",
       " ('Case presentation', 71),\n",
       " ('Measures', 70),\n",
       " ('Nucleotide sequence accession numbers', 70),\n",
       " ('6. Conclusions', 70),\n",
       " ('Immunofluorescence assay', 69),\n",
       " ('Data Availability Statement', 69),\n",
       " ('References', 69),\n",
       " ('Microbiology', 69),\n",
       " ('Disclosure', 68),\n",
       " ('Case Report', 68),\n",
       " ('Model', 67),\n",
       " ('BACKGROUND', 67),\n",
       " ('Objective', 67),\n",
       " ('DATA AVAILABILITY STATEMENT', 67),\n",
       " ('Recommendations', 67),\n",
       " ('SUPPLEMENTAL INFORMATION', 67),\n",
       " ('5. Conclusion', 67),\n",
       " ('Conflicto de intereses', 67),\n",
       " ('Phylogenetic analyses', 66),\n",
       " ('Consent for publication', 66),\n",
       " ('General', 66),\n",
       " ('Figure 1.', 66),\n",
       " ('Pathophysiology', 66),\n",
       " ('Study population ::: Methods', 66),\n",
       " ('11', 65),\n",
       " ('Availability of data and materials', 65),\n",
       " ('Patients and methods', 65),\n",
       " ('Design', 65),\n",
       " ('Quantitative real-time PCR', 65),\n",
       " ('Future perspectives', 65),\n",
       " ('PREVENTION', 65),\n",
       " ('Statistics ::: Materials and Methods', 65),\n",
       " ('Mice ::: Materials and Methods', 65),\n",
       " ('Statistical analysis. ::: MATERIALS AND METHODS', 65),\n",
       " ('5', 64),\n",
       " ('Material and Methods', 64),\n",
       " ('Ethics approval and consent to participate', 64),\n",
       " ('Implications of all the available evidence', 64),\n",
       " ('Sample preparation', 64),\n",
       " ('Clinical Signs', 64),\n",
       " ('Table 3', 64),\n",
       " ('Ethical statement', 62),\n",
       " ('Real-time RT-PCR', 62),\n",
       " ('Participants ::: Methods', 62),\n",
       " ('Transmission electron microscopy', 61),\n",
       " ('Parasites', 61),\n",
       " ('ELISA ::: Materials and Methods', 61),\n",
       " ('Abstract', 60),\n",
       " ('Clinical specimens', 60),\n",
       " ('Ethics Statement ::: Methods', 60),\n",
       " ('Key issues', 60),\n",
       " ('PATHOGENESIS', 60),\n",
       " ('Study design and participants', 59),\n",
       " ('Accession numbers', 59),\n",
       " ('Western Blotting', 59),\n",
       " ('Immunofluorescence microscopy', 59),\n",
       " ('Experimental animals', 59),\n",
       " ('Virology', 59),\n",
       " ('History', 59),\n",
       " ('Flow cytometry ::: Materials and Methods', 59),\n",
       " ('Western blot analysis ::: Materials and Methods', 59),\n",
       " ('Western blot analysis ::: Materials and methods', 59),\n",
       " ('Conflict of Interest ::: Author Contributions', 59),\n",
       " ('SARS', 58),\n",
       " ('Compounds', 58),\n",
       " ('Antiviral activity', 58),\n",
       " ('Case description', 58),\n",
       " ('In Brief', 58),\n",
       " ('DATA AVAILABILITY', 57),\n",
       " ('Conclusion:', 57),\n",
       " ('Research in context', 57),\n",
       " ('7.', 57),\n",
       " ('STAR+METHODS', 57),\n",
       " ('Ethics ::: Methods', 57),\n",
       " ('Western blotting ::: Materials and methods', 57),\n",
       " ('Specimens', 56),\n",
       " ('ACCESSION NUMBERS', 56),\n",
       " ('Disclosures', 55),\n",
       " ('Discussion and Conclusions', 55),\n",
       " ('Flow cytometry analysis', 55),\n",
       " ('Statistical Methods', 55),\n",
       " ('Cell cultures', 55),\n",
       " ('Future Directions', 55),\n",
       " ('Sample collection ::: Materials and methods', 55),\n",
       " ('Results:', 54),\n",
       " ('Figure 3', 54),\n",
       " ('Demographics', 54),\n",
       " ('Clinical Features', 54),\n",
       " ('Construction of plasmids', 54),\n",
       " ('6.', 54),\n",
       " ('Analysis ::: Methods', 54),\n",
       " ('Data ::: Methods', 54),\n",
       " ('Statistics ::: Materials and methods', 54),\n",
       " ('Data availability ::: Methods', 54),\n",
       " ('3', 53),\n",
       " ('Differential diagnosis', 53),\n",
       " ('Supplementary Data', 53),\n",
       " ('Primers', 53),\n",
       " ('Western blot analysis ::: Methods', 53),\n",
       " ('Cells and viruses ::: Materials and Methods', 53),\n",
       " ('Cell culture ::: Materials and Methods', 53),\n",
       " ('Statistical analyses ::: Materials and methods', 53),\n",
       " ('4', 52),\n",
       " ('Western Blot', 52),\n",
       " ('CASE REPORT', 52),\n",
       " ('Antibiotics', 52),\n",
       " ('Data analysis ::: Materials and methods', 52),\n",
       " ('Statistical analyses ::: Materials and Methods', 52),\n",
       " ('Flow cytometry ::: Methods', 52),\n",
       " ('Notes', 51),\n",
       " ('Outlook', 51),\n",
       " ('Experimental', 51),\n",
       " ('DIFFERENTIAL DIAGNOSIS', 51),\n",
       " ('Respiratory Syncytial Virus', 51),\n",
       " ('Primer design', 51),\n",
       " ('Therapy', 51),\n",
       " ('Conclusions and future perspectives', 51),\n",
       " ('Statistical methods ::: Methods', 51),\n",
       " ('Statistical Analyses ::: Materials and Methods', 51),\n",
       " ('10', 50),\n",
       " ('Microscopy', 50),\n",
       " ('Strengths and limitations', 50),\n",
       " ('Challenges', 50),\n",
       " ('Quantitative RT-PCR', 50),\n",
       " ('Immunization', 50),\n",
       " ('Key messages', 50),\n",
       " ('Cytomegalovirus', 50),\n",
       " ('Plasmids ::: Materials and Methods', 50),\n",
       " ('Cells and viruses ::: Materials and methods', 50),\n",
       " ('Conclusions ::: Discussion', 50),\n",
       " ('Neoplasia', 50),\n",
       " ('Overview', 49),\n",
       " ('QUANTIFICATION AND STATISTICAL ANALYSIS', 49),\n",
       " ('Virus Isolation', 49),\n",
       " ('Immunofluorescence assay (IFA)', 49),\n",
       " ('Fungi', 49),\n",
       " ('Western blotting ::: Methods', 49),\n",
       " ('Data source', 48),\n",
       " ('Measles', 48),\n",
       " ('Neutralization assay', 48),\n",
       " ('Flow cytometry ::: Materials and methods', 48),\n",
       " ('Sample Collection', 47),\n",
       " ('Definition', 47),\n",
       " ('Cell culture and transfection', 47),\n",
       " ('Escherichia coli', 47),\n",
       " ('Flow cytometric analysis', 47),\n",
       " ('Cell culture ::: Materials and methods', 47),\n",
       " ('Cells and viruses ::: Methods', 47),\n",
       " ('Cells ::: Materials and Methods', 47),\n",
       " ('Confl icts of interest', 47),\n",
       " ('Availability and requirements', 46),\n",
       " ('9', 46),\n",
       " ('Methods:', 46),\n",
       " ('Implementation', 46),\n",
       " ('List of abbreviations', 46),\n",
       " ('Laboratory methods', 46),\n",
       " ('Consent', 46),\n",
       " ('Virus infection', 46),\n",
       " ('Viruses ::: Materials and Methods', 46),\n",
       " ('Animals ::: Materials and methods', 46),\n",
       " ('Statistical analysis ::: Material and methods', 46),\n",
       " ('Table 4', 46),\n",
       " ('Keywords', 45),\n",
       " ('Interventions', 45),\n",
       " ('Case 2', 45),\n",
       " ('Peptide synthesis', 45),\n",
       " ('Additional information', 45),\n",
       " ('Immunoprecipitation', 45),\n",
       " ('PCR', 45),\n",
       " ('Differential Diagnosis', 45),\n",
       " ('Ribavirin', 45),\n",
       " ('Ethics approval', 44),\n",
       " ('DNA extraction', 44),\n",
       " ('Rabies', 44),\n",
       " ('Experimental Design', 44),\n",
       " ('Specimen collection', 44),\n",
       " ('Safety', 44),\n",
       " ('Sample', 44),\n",
       " ('Rhinovirus', 44),\n",
       " ('Sample collection ::: Methods', 44),\n",
       " ('Result', 43),\n",
       " ('Quantitative PCR', 43),\n",
       " ('Procedure', 43),\n",
       " ('DNA sequencing', 43),\n",
       " ('Clinical presentation', 43),\n",
       " ('Western blotting analysis', 43),\n",
       " ('Mice ::: Methods', 43),\n",
       " ('Phylogenetic analysis ::: Results', 43),\n",
       " ('7. Conclusions', 43),\n",
       " ('7', 42),\n",
       " ('Conclusions:', 42),\n",
       " ('Mass spectrometry', 42),\n",
       " ('Ethical Considerations', 42),\n",
       " ('Recombination analysis', 42),\n",
       " ('Bioinformatics', 42),\n",
       " ('Additional material', 42),\n",
       " ('Antibodies and reagents', 42),\n",
       " ('statistical analysis', 42),\n",
       " ('Dear Editor,', 42),\n",
       " ('Norovirus', 42),\n",
       " ('Miscellaneous', 42),\n",
       " ('CLINICAL FEATURES', 42),\n",
       " ('Viruses ::: Materials and methods', 42),\n",
       " ('Western blotting ::: Materials and Methods', 42),\n",
       " ('Tratamiento', 42),\n",
       " ('6', 41),\n",
       " ('19', 41),\n",
       " ('Gene', 41),\n",
       " ('Disclosure statement', 41),\n",
       " ('Clinical characteristics', 41),\n",
       " ('Interpretation', 41),\n",
       " ('Figure 4', 41),\n",
       " ('Indirect immunofluorescence assay (IFA)', 41),\n",
       " ('Disclosure of Potential Conflicts of Interest', 41),\n",
       " ('Complications', 41),\n",
       " ('Influenza virus', 41),\n",
       " ('Patient characteristics ::: Results', 41),\n",
       " ('Phylogenetic analysis ::: Materials and methods', 41),\n",
       " ('Inclusion and exclusion criteria', 40),\n",
       " ('Sample size', 40),\n",
       " ('Study participants', 40),\n",
       " ('Histopathology and immunohistochemistry', 40),\n",
       " ('Adenoviruses', 40),\n",
       " ('Future perspective', 40),\n",
       " ('Antibodies ::: Materials and Methods', 40),\n",
       " ('15', 39),\n",
       " ('Crystallization', 39),\n",
       " ('Study area', 39),\n",
       " ('Specificity', 39),\n",
       " ('| Statistical analysis', 39),\n",
       " ('Microarray analysis', 39),\n",
       " ('MTT assay', 39),\n",
       " ('Northern blot analysis', 39),\n",
       " ('Questionnaire', 39),\n",
       " ('Study subjects', 39),\n",
       " ('Staphylococcus aureus', 39),\n",
       " ('Patients ::: Methods', 39),\n",
       " ('1', 38),\n",
       " ('Conflict of interests', 38),\n",
       " ('Sequence Analysis', 38),\n",
       " ('Clinical manifestations', 38),\n",
       " ('Perspective', 38),\n",
       " ('Transfection', 38),\n",
       " ('Virus detection', 38),\n",
       " ('Classification', 38),\n",
       " ('Clostridium difficile', 38),\n",
       " ('Pneumonia', 38),\n",
       " ('Conclusions and future directions', 38),\n",
       " ('Corticosteroids', 38),\n",
       " ('Clinical Presentation', 38),\n",
       " ('Data sharing', 37),\n",
       " ('Figure 1', 37),\n",
       " ('Immunocytochemistry', 37),\n",
       " ('Declaration of interest', 37),\n",
       " ('Measurements', 37),\n",
       " ('Cells and Virus', 37),\n",
       " ('Compliance with Ethical Standards', 37),\n",
       " ('Luciferase assay', 37),\n",
       " ('Editorial', 37),\n",
       " ('Glossary', 37),\n",
       " ('Hepatitis B', 37),\n",
       " ('Conclusiones', 37),\n",
       " ('Study selection', 36),\n",
       " ('Acknowledgement', 36),\n",
       " ('Site-directed mutagenesis', 36),\n",
       " ('Data extraction', 36),\n",
       " ('Indirect immunofluorescence assay', 36),\n",
       " ('DiscUssiOn', 36),\n",
       " ('Viral infections', 36),\n",
       " ('Conclusions and Perspectives', 36),\n",
       " ('Necropsy', 36),\n",
       " ('Data collection and analysis', 36),\n",
       " ('Cancer', 36),\n",
       " ('A B S T R A C T', 36),\n",
       " ('Viral Infections', 36),\n",
       " ('FUTURE DIRECTIONS', 36),\n",
       " ('Results and discussions', 36),\n",
       " ('Protozoa', 36),\n",
       " ('Conclusion ::: Discussion', 36),\n",
       " ('DiagnÃ³stico', 36),\n",
       " ('8', 35),\n",
       " ('Introduction:', 35),\n",
       " ('The model', 35),\n",
       " ('Animal experiments', 35),\n",
       " ('Supplementary Materials:', 35),\n",
       " ('Case 1', 35),\n",
       " ('Transmission electron microscopy (TEM)', 35),\n",
       " ('HIV', 35),\n",
       " ('Herpesviruses', 35),\n",
       " ('Statistical Analysis.', 35),\n",
       " ('Reagents and antibodies', 35),\n",
       " ('West Nile Virus', 35),\n",
       " ('Open Access', 35),\n",
       " ('Bioinformatics analysis', 35),\n",
       " ('Prevention and Control', 35),\n",
       " ('Supplementary data', 35),\n",
       " ('Declarations of interest', 35),\n",
       " ('Cell culture ::: Methods', 35),\n",
       " ('Materials ::: Materials and Methods', 35),\n",
       " ('Statistical analysis ::: METHODS', 35),\n",
       " ('13', 34),\n",
       " ('Plasmid Construction', 34),\n",
       " ('Supplementary information', 34),\n",
       " ('Patients and samples', 34),\n",
       " ('Availability of supporting data', 34),\n",
       " ('RNA isolation', 34),\n",
       " ('Cytotoxicity Assay', 34),\n",
       " ('J o u r n a l P r e -p r o o f', 34),\n",
       " ('Competing interest', 34),\n",
       " ('Immunofluorescence staining', 34),\n",
       " ('Infections', 34),\n",
       " ('Surveillance', 34),\n",
       " ('Monoclonal antibodies', 34),\n",
       " ('Anthrax', 34),\n",
       " ('Study population ::: Results', 34),\n",
       " ('Viruses ::: Methods', 34),\n",
       " ('ELISA ::: Materials and methods', 34),\n",
       " ('Physical Examination', 34),\n",
       " ('Bacterial Infections', 34),\n",
       " ('Mycobacterium tuberculosis', 34),\n",
       " ('Age', 33),\n",
       " ('Implications', 33),\n",
       " ('Transparency declaration', 33),\n",
       " ('Other Viruses', 33),\n",
       " ('| D ISCUSS I ON', 33),\n",
       " ('Serum samples', 33),\n",
       " ('Disclosure of potential conflicts of interest', 33),\n",
       " ('Future Perspectives', 33),\n",
       " ('Study limitations', 33),\n",
       " ('| INTRODUCTION', 33),\n",
       " ('Human Immunodeficiency Virus', 33),\n",
       " ('Salmonellosis', 33),\n",
       " ('Outstanding Questions', 33),\n",
       " ('Clinical observations', 33),\n",
       " ('Influenza Virus', 33),\n",
       " ('Summary and conclusions', 33),\n",
       " ('Risk factors', 33),\n",
       " ('CLINICAL MANIFESTATIONS', 33),\n",
       " ('Respiratory syncytial virus', 33),\n",
       " ('ELISA ::: Methods', 33),\n",
       " ('Data Analysis ::: Methods', 33),\n",
       " ('Flow Cytometry ::: Materials and Methods', 33),\n",
       " ('Ethical considerations ::: Methods', 33),\n",
       " ('Ethical approval ::: Materials and Methods', 33),\n",
       " ('Traitement', 33),\n",
       " ('Experimental Procedures', 32),\n",
       " ('qRT-PCR', 32),\n",
       " ('8.', 32),\n",
       " ('CONFLICTS OF INTEREST', 32),\n",
       " ('Primer', 32),\n",
       " ('Leptospirosis', 32),\n",
       " ('Immunofluorescence analysis', 32),\n",
       " ('Infection', 32),\n",
       " ('Plasmid constructs', 32),\n",
       " ('ETIOLOGY', 32),\n",
       " ('Funding source', 32),\n",
       " ('RNA interference', 32),\n",
       " ('Bacterial infections', 32),\n",
       " ('MERS-CoV', 32),\n",
       " ('Antibodies ::: Materials and methods', 32),\n",
       " ('Immunofluorescence ::: Materials and Methods', 32),\n",
       " ('Data analysis ::: Materials and Methods', 32),\n",
       " ('Western Blot Analysis ::: Materials and Methods', 32),\n",
       " ('4. Conclusion', 32),\n",
       " ('â–  INTRODUCTION', 32),\n",
       " ('Fig. 5.', 32),\n",
       " ('KEY POINTS', 32),\n",
       " ('Expert opinion', 32),\n",
       " ('ACKNOWLEDGMENT', 31),\n",
       " ('Synthesis', 31),\n",
       " ('Mortality', 31),\n",
       " ('| DISCUSSION', 31),\n",
       " ('Ethical Approval', 31),\n",
       " ('Symptoms', 31),\n",
       " ('Vaccine', 31),\n",
       " ('Outcome measures', 31),\n",
       " ('Conclusions and Future Perspectives', 31),\n",
       " ('RSV', 31),\n",
       " ('Cell Lines', 31),\n",
       " ('Inclusion criteria', 31),\n",
       " ('Laboratory diagnosis', 31),\n",
       " ('Multilingual abstracts', 31),\n",
       " ('Phylogenetic analysis ::: Methods', 31),\n",
       " ('8. Conclusions', 31),\n",
       " ('CLINICAL SIGNS', 31),\n",
       " ('Acknowledgment', 30),\n",
       " ('Name', 30),\n",
       " ('Funding sources', 30),\n",
       " ('Laboratory testing', 30),\n",
       " ('Viral infection', 30),\n",
       " ('| INTRODUC TI ON', 30),\n",
       " ('Asthma', 30),\n",
       " ('Others', 30),\n",
       " ('Culture', 30),\n",
       " ('Immunoblot analysis', 30),\n",
       " ('Dengue', 30),\n",
       " ('DATA AND SOFTWARE AVAILABILITY', 30),\n",
       " ('RNA extraction and cDNA synthesis', 30),\n",
       " ('Polymerase chain reaction', 30),\n",
       " ('Molecular analysis', 30),\n",
       " ('Patients and Methods', 30),\n",
       " ('Hepatitis C', 30),\n",
       " ('Immunohistochemistry ::: Methods', 30),\n",
       " ('Phylogenetic analysis ::: Materials and Methods', 30),\n",
       " ('5. Discussion', 30),\n",
       " ('Ethical approval ::: Methods', 30),\n",
       " ('EpidemiologÃ­a', 30),\n",
       " ('18', 29),\n",
       " ('21', 29),\n",
       " ('Analyses', 29),\n",
       " ('Strengths and limitations of this study', 29),\n",
       " ('Key points', 29),\n",
       " ('Control', 29),\n",
       " ('Simulations', 29),\n",
       " (\"Authors' Contributions\", 29),\n",
       " ('Exclusion criteria', 29),\n",
       " ('RNA Extraction', 29),\n",
       " ('Sequence and phylogenetic analysis', 29),\n",
       " ('Imaging', 29),\n",
       " ('Structure', 29),\n",
       " ('Bacteriology', 29),\n",
       " ('Instruments', 29),\n",
       " ('Virus strains', 29),\n",
       " ('Indirect immunofluorescence', 29),\n",
       " ('10.', 29),\n",
       " ('9.', 29),\n",
       " ('Toxoplasmosis', 29),\n",
       " ('Materials ::: Materials and methods', 29),\n",
       " ('Subjects ::: Methods', 29),\n",
       " ('Plasmids ::: Methods', 29),\n",
       " ('Study design ::: Materials and methods', 29),\n",
       " ('Immunoblotting ::: Materials and Methods', 29),\n",
       " ('Disclosure of interest', 29),\n",
       " ('Western blot ::: Materials and methods', 29),\n",
       " ('Ethics statement ::: MATERIALS AND METHODS', 29),\n",
       " ('I N T R O D U C T I O N', 29),\n",
       " ('MANAGEMENT', 29),\n",
       " ('16', 28),\n",
       " ('12', 28),\n",
       " ('22', 28),\n",
       " ('Sensitivity Analysis', 28),\n",
       " ('Case definition', 28),\n",
       " ('SARS-CoV', 28),\n",
       " ('Cell viability', 28),\n",
       " ('Fluorescence microscopy', 28),\n",
       " ('Clinical data', 28),\n",
       " ('Peptides', 28),\n",
       " ('Statistical', 28),\n",
       " ('Conclusions and Future Directions', 28),\n",
       " ('CLINICAL PRESENTATION', 28),\n",
       " ('Antiviral assays', 28),\n",
       " ('Salmonella', 28),\n",
       " ('ELISPOT assay', 28),\n",
       " ('Cats', 28),\n",
       " ('Setting ::: Methods', 28),\n",
       " ('Cells ::: Materials and methods', 28),\n",
       " ('Data sources ::: Methods', 28),\n",
       " ('1. Background', 28),\n",
       " ('Cell Culture ::: Materials and Methods', 28),\n",
       " ('2. Materials and Methods', 28),\n",
       " ('Manifestaciones clÃ­nicas', 28),\n",
       " ('Chemicals and reagents', 27),\n",
       " ('Statistical analysis.', 27),\n",
       " ('3.2.', 27),\n",
       " ('Patient and public involvement', 27),\n",
       " ('Intervention', 27),\n",
       " ('Author contribution', 27),\n",
       " ('AUTHOR CONTRiBUTiONS', 27),\n",
       " ('Coronaviridae', 27),\n",
       " ('Hematology', 27),\n",
       " ('Viruses and Cells', 27),\n",
       " ('Immunohistochemistry (IHC)', 27),\n",
       " ('Immunofluorescence Microscopy', 27),\n",
       " ('Influenza Viruses', 27),\n",
       " ('Western blot assay', 27),\n",
       " ('Immunization of mice', 27),\n",
       " ('Plaque reduction assay', 27),\n",
       " ('Infectious Diseases', 27),\n",
       " ('Replication', 27),\n",
       " ('Immunity', 27),\n",
       " ('Retroviruses', 27),\n",
       " ('Trauma', 27),\n",
       " ('Statistical analysis ::: Patients and methods', 27),\n",
       " ('Data Collection ::: Methods', 27),\n",
       " ('Immunohistochemistry ::: Materials and Methods', 27),\n",
       " ('Plasmids ::: Materials and methods', 27),\n",
       " ('Experimental design ::: Materials and methods', 27),\n",
       " ('Strengths and limitations ::: Discussion', 27),\n",
       " ('Protein purification', 26),\n",
       " ('RT-qPCR', 26),\n",
       " ('Co-immunoprecipitation', 26),\n",
       " ('Molecular docking', 26),\n",
       " ('Clinical Findings', 26),\n",
       " ('Western blots', 26),\n",
       " ('Viruses and cell lines', 26),\n",
       " ('Flaviviruses', 26),\n",
       " ('Cytotoxicity', 26),\n",
       " ('Plasmid constructions', 26),\n",
       " ('Virus neutralization assay', 26),\n",
       " ('Luciferase reporter assay', 26),\n",
       " ('Cytotoxicity assays', 26),\n",
       " ('Genotyping', 26),\n",
       " ('Inflammation', 26),\n",
       " ('Herpes Simplex Virus', 26),\n",
       " ('Antivirals', 26),\n",
       " ('Case', 26),\n",
       " ('SDS-PAGE and Western blot analysis', 26),\n",
       " ('Key Points', 26),\n",
       " ('Conclusions and outlook', 26),\n",
       " ('Human immunodeficiency virus', 26),\n",
       " ('Clinical Manifestations', 26),\n",
       " ('Search strategy ::: Methods', 26),\n",
       " ('Nucleic acid extraction ::: Methods', 26),\n",
       " ('Statistical analysis ::: Material and Methods', 26),\n",
       " ('Nucleotide sequence accession number. ::: GENOME ANNOUNCEMENT', 26),\n",
       " ('Cells and viruses. ::: MATERIALS AND METHODS', 26),\n",
       " ('Authorsâ€™ Contributions', 26),\n",
       " ('DiscusiÃ³n', 26),\n",
       " ('PROGNOSIS', 26),\n",
       " ('Severe Acute Respiratory Syndrome', 26),\n",
       " ('17', 25),\n",
       " ('Discussion and Conclusion', 25),\n",
       " ('2', 25),\n",
       " ('Bioinformatic analysis', 25),\n",
       " ('Clinical findings', 25),\n",
       " ('Drugs', 25),\n",
       " ('Reverse transcription', 25),\n",
       " ('Ferrets', 25),\n",
       " ('Paramyxoviridae', 25),\n",
       " ('Sensitivity', 25),\n",
       " ('Bacterial strains', 25),\n",
       " ('Study setting', 25),\n",
       " ('Herpesviridae', 25),\n",
       " ('Seasonality', 25),\n",
       " ('Cytokines', 25),\n",
       " ('Interferons', 25),\n",
       " ('Other viruses', 25),\n",
       " ('Risk Factors', 25),\n",
       " ('PATHOPHYSIOLOGY', 25),\n",
       " ('Enteroviruses', 25),\n",
       " ('Financial support', 25),\n",
       " ('NMR spectroscopy', 25),\n",
       " ('Study Design ::: Methods', 25),\n",
       " ('Statistical Analyses ::: Methods', 25),\n",
       " ('Mice ::: Materials and methods', 25),\n",
       " ('3. Results and Discussion', 25),\n",
       " ('Ethics statement. ::: MATERIALS AND METHODS', 25),\n",
       " ('PATHOLOGY', 25),\n",
       " ('Related work', 24),\n",
       " ('Image analysis', 24),\n",
       " ('Study design and patients', 24),\n",
       " ('Main text', 24),\n",
       " ('In vitro transcription', 24),\n",
       " ('Eligibility criteria', 24),\n",
       " ('Species', 24),\n",
       " ('13.', 24),\n",
       " ('Demographic characteristics', 24),\n",
       " ('Immunostaining', 24),\n",
       " ('Sequence data', 24),\n",
       " ('CONTACT FOR REAGENT AND RESOURCE SHARING', 24),\n",
       " ('Nucleotide sequence accession number', 24),\n",
       " ('Cell lines and viruses', 24),\n",
       " ('Sequencing and phylogenetic analysis', 24),\n",
       " ('Infection control', 24),\n",
       " ('Confocal Microscopy', 24),\n",
       " ('Animals and experimental design', 24),\n",
       " ('Plaque Assay', 24),\n",
       " ('Population', 24),\n",
       " ('Viral RNA extraction', 24),\n",
       " ('SUMMARY AND CONCLUSIONS', 24),\n",
       " ('Hantavirus', 24),\n",
       " ('Helicobacter pylori', 24),\n",
       " ('Dogs', 24),\n",
       " ('Genetics', 24),\n",
       " ('Virus preparation', 24),\n",
       " ('Applications', 24),\n",
       " ('Proteins', 24),\n",
       " ('Incidence', 24),\n",
       " ('Listeria monocytogenes', 24),\n",
       " ('Study population ::: Materials and methods', 24),\n",
       " ('Western blot ::: Methods', 24),\n",
       " ('Electron microscopy ::: Materials and Methods', 24),\n",
       " ('Cells and Viruses ::: Materials and Methods', 24),\n",
       " ('6. Conclusion', 24),\n",
       " ('2.9. Statistical Analysis ::: 2. Materials and Methods', 24),\n",
       " ('Nutrition', 24),\n",
       " ('Transparency document', 24),\n",
       " ('Author Manuscript', 24),\n",
       " ('Discussion:', 23),\n",
       " ('Conflict of Interests', 23),\n",
       " ('Funding information', 23),\n",
       " ('Transmission Electron Microscopy', 23),\n",
       " ('Outcome', 23),\n",
       " ('Data Sources', 23),\n",
       " ('Reference', 23),\n",
       " ('Subcellular fractionation', 23),\n",
       " ('Variables', 23),\n",
       " ('Immunofluorescence Assay', 23),\n",
       " ('Indirect ELISA', 23),\n",
       " ('Human metapneumovirus', 23),\n",
       " ('Influenza viruses', 23),\n",
       " ('Neutrophils', 23),\n",
       " ('Primer and probe design', 23),\n",
       " ('Patient Characteristics', 23),\n",
       " ('RNA Viruses', 23),\n",
       " ('Intracellular cytokine staining', 23),\n",
       " ('Animal studies', 23),\n",
       " ('Smallpox', 23),\n",
       " ('Astrovirus', 23),\n",
       " ('Materials and reagents', 23),\n",
       " ('Housing', 23),\n",
       " ('VIRUSES', 23),\n",
       " ('Interferon', 23),\n",
       " ('Radiology', 23),\n",
       " ('Polymerase chain reaction (PCR)', 23),\n",
       " ('Cells ::: Methods', 23),\n",
       " ('Samples ::: Methods', 23),\n",
       " ('Definitions ::: Methods', 23),\n",
       " ('Data Analysis ::: Materials and Methods', 23),\n",
       " ('Electron microscopy ::: Materials and methods', 23),\n",
       " ('Reagents ::: Materials and methods', 23),\n",
       " ('Virus titration ::: Materials and methods', 23),\n",
       " ('Funding statement', 23),\n",
       " ('Sequence analysis ::: Materials and methods', 23),\n",
       " ('Reporting summary ::: Methods', 23),\n",
       " ('Feline Infectious Peritonitis', 23),\n",
       " ('â–  CONCLUSIONS', 23),\n",
       " ('Brucellosis', 23),\n",
       " ('D I S C U S S I O N', 23),\n",
       " (\"DÃ©claration d'intÃ©rÃªts\", 23),\n",
       " ('27', 22),\n",
       " ('Parameter', 22),\n",
       " ('Animal models', 22),\n",
       " ('MATERIAL AND METHODS', 22),\n",
       " ('Communication', 22),\n",
       " ('Antibody detection', 22),\n",
       " ('Sample processing', 22),\n",
       " ('Plant material', 22),\n",
       " ('Flaviviridae', 22),\n",
       " ('Limitations of the study', 22),\n",
       " ('Probiotics', 22),\n",
       " ('Laboratory Testing', 22),\n",
       " ('Methods and Findings', 22),\n",
       " ('Group', 22),\n",
       " ('Enzyme-linked immunosorbent assay', 22),\n",
       " ('Diagnostics', 22),\n",
       " ('GenBank accession numbers', 22),\n",
       " ('Clinical evaluation', 22),\n",
       " ('Pigs', 22),\n",
       " ('METHOD DETAILS', 22),\n",
       " ('Liposomes', 22),\n",
       " ('Plaque assays', 22),\n",
       " ('Financial & competing interests disclosure', 22),\n",
       " ('12.', 22),\n",
       " ('Prevalence', 22),\n",
       " ('Streptococcus pneumoniae', 22),\n",
       " ('Preparation', 22),\n",
       " ('KEYWORDS', 22),\n",
       " ('Viruses and cells ::: Methods', 22),\n",
       " ('Accession numbers ::: Materials and Methods', 22),\n",
       " ('Virus ::: Methods', 22),\n",
       " ('Western Blotting ::: Materials and Methods', 22),\n",
       " ('Reagents ::: Materials and Methods', 22),\n",
       " ('Histopathology ::: Materials and Methods', 22),\n",
       " ('Sample collection ::: Materials and Methods', 22),\n",
       " ('RNA extraction ::: Materials and methods', 22),\n",
       " ('REVIEWS', 22),\n",
       " ('Future prospects', 22),\n",
       " ('ConclusiÃ³n', 22),\n",
       " ('FIG. 2.', 22),\n",
       " ('Resultados', 22),\n",
       " ('Surgery', 22),\n",
       " ('Mathematical model', 21),\n",
       " ('Supplementary', 21),\n",
       " ('As shown in', 21),\n",
       " ('Pharmacokinetics', 21),\n",
       " ('Histological analysis', 21),\n",
       " ('Laboratory findings', 21),\n",
       " ('Monitoring', 21),\n",
       " ('Experimental procedures', 21),\n",
       " ('Structure determination', 21),\n",
       " ('Virus Titration', 21),\n",
       " ('Accession Numbers', 21),\n",
       " ('Autophagy', 21),\n",
       " ('Study Limitations', 21),\n",
       " ('Quantitative real-time RT-PCR', 21),\n",
       " ('Study design and population', 21),\n",
       " ('Sample collection and processing', 21),\n",
       " ('Macrophages', 21),\n",
       " ('CONCLUSIONS AND PERSPECTIVES', 21),\n",
       " ('(DOC)', 21),\n",
       " ('Luciferase assays', 21),\n",
       " ('Cell proliferation assay', 21),\n",
       " ('Genome sequencing', 21),\n",
       " ('RNA extraction and RT-PCR', 21),\n",
       " ('Purpose', 21),\n",
       " ('Data analyses', 21),\n",
       " ('Immunizations', 21),\n",
       " ('Histopathological examination', 21),\n",
       " ('Patients and specimens', 21),\n",
       " ('Future Prospects', 21),\n",
       " ('Viral', 21),\n",
       " ('DNA Viruses', 21),\n",
       " ('Laboratory Diagnosis', 21),\n",
       " ('Toxicity', 21),\n",
       " ('Rhinoviruses', 21),\n",
       " ('Executive summary', 21),\n",
       " ('Sepsis', 21),\n",
       " ('Cholera', 21),\n",
       " ('Cryptosporidiosis', 21),\n",
       " ('Measures ::: Methods', 21),\n",
       " ('Phylogenetic Analysis ::: Materials and Methods', 21),\n",
       " ('Clinical samples ::: Methods', 21),\n",
       " ('Sensitivity analysis ::: Results', 21),\n",
       " ('Sampling ::: Methods', 21),\n",
       " ('Reagents ::: Methods', 21),\n",
       " ('3. Conclusions', 21),\n",
       " ('Authorsâ€™ information', 21),\n",
       " ('Immunofluorescence ::: Materials and methods', 21),\n",
       " ('Accession number(s). ::: MATERIALS AND METHODS', 21),\n",
       " ('EtiologÃ­a', 21),\n",
       " ('BibliografÃ­a', 21),\n",
       " ('Table 6', 21),\n",
       " ('Appendix A. Supplementary data', 21),\n",
       " ('20', 20),\n",
       " ('Numerical simulations', 20),\n",
       " ('Clinical outcomes', 20),\n",
       " ('Limitation', 20),\n",
       " ('Follow-up', 20),\n",
       " ('Keywords:', 20),\n",
       " ('Patient population', 20),\n",
       " ('Contributions', 20),\n",
       " ('Circular dichroism spectroscopy', 20),\n",
       " ('Picornaviridae', 20),\n",
       " ('CO N FLI C T O F I NTE R E S T', 20),\n",
       " ('Environment', 20),\n",
       " ('Descriptive statistics', 20),\n",
       " ('DNA vaccines', 20),\n",
       " ('Survey', 20),\n",
       " ('Microarray', 20),\n",
       " ('Adjuvants', 20),\n",
       " ('Morphology', 20),\n",
       " ('Radiography', 20),\n",
       " ('Experimental infection', 20),\n",
       " ('Advantages', 20),\n",
       " ('SDS-PAGE', 20),\n",
       " ('Histopathology and Immunohistochemistry', 20),\n",
       " ('Gene expression analysis', 20),\n",
       " ('Simulation results', 20),\n",
       " ('Cell and virus', 20),\n",
       " ('Epstein-Barr Virus', 20),\n",
       " ('Virus identification', 20),\n",
       " ('Study design and setting', 20),\n",
       " ('LIMITATIONS', 20),\n",
       " ...]"
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted(sections.items(), key=lambda x: x[1], reverse=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "52097"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "class Paper:\n",
    "    def __init__(self, )"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
